Sequential Granulocyte Colony-Stimulating Factor Increases Cisplatin Cytotoxicity in Human Epithelial Ovarian Cancer Cell Lines

Author： Fanning J.   Hilgers R.D.   Kane C.   Medrano C.  

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.60, Iss.3, 1996-03, pp. : 450-453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer

By Mori K.   Hirose T.   Machida S.   Yokoyama K.   Tominaga K.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 503-505

Elsevier

Access to resources Recommend Favorite

Prophylactic Granulocyte Colony-Stimulating Factor Allows Escalation of Chemotherapeutic Dose Intensity in Advanced Epithelial Ovarian Cancer

By Fanning J.   Hilgers R.D.  

Gynecologic Oncology, Vol. 63, Iss. 3, 1996-12 ,pp. : 323-327

Academic Press

Access to resources Recommend Favorite

A Phase II Double-Blind Randomized Study of the Simultaneous Administration of Recombinant Human Interleukin-6 and Recombinant Human Granulocyte Colony-Stimulating Factor Following Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer

By Hochster H.   Speyer J.L.   Mandeli J.P.   Runowicz C.   Wadler S.   Berk G.   Wallach R.   Holland J.F.   for the New York Gynecologic Oncology Group  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 292-297

Elsevier

Access to resources Recommend Favorite

Growth stimulation of non-small cell lung cancer xenografts by granulocyte-macrophage colony-stimulating factor (GM-CSF)

By Oshika Y.   Nakamura M.   Abe Y.   Fukuchi Y.   Yoshimura M.   Itoh M.   Ohnishi Y.   Tokunaga T.   Fukushima Y.   Hatanaka H.   Kijima H.   Yamazaki H.   Tamaoki N.   Ueyama Y.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1958-1961

Elsevier

Access to resources Recommend Favorite

Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer

By Tung N.   Berkowitz R.   Matulonis U.   Quartulli M.   Seiden M.   Kim Y.   Niloff J.   Cannistra S.A.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite